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Inhibition of atherosclerosis progression has long been the subject of intensive pathophysiologic 
investigations. The identification of a novel target molecule to redeem the cellular processes remains a 
major challenge in cardiology. Signal peptide CUB domain EGF-like repeat protein (SCUBE) family has 
been detected on human tissues and cultured cells. Two members of the SCUBE family, SCUBE1 and 
SCUBE3 are reported to play a role in cardiovascular diseases. The other member, SCUBE2 has been 
reported to mediate Hedgehog (Hh) protein signaling and is expressed in major blood vessels during 
mouse embryogenesis. However its involvement in cardiovascular diseases is not known yet. The aim of 
this study was to investigate SCUBE2 expression and localization in diffuse intimal thickening (DIT), an 
early event of atherosclerosis and in advanced lesion of atherosclerotic plaque. 
Carotid artery ligation in C57BL/6J mice was performed to induce intimal thickening, mimicking DIT 
in human. After 2 weeks of ligation, mRNA level of SCUBE2 increased significantly, while in LDLr-/- mice 
fed with high fat diet, a human atherosclerosis model, mRNA level of SCUBE2 expression markedly 
increased 8 weeks after start of the high fat diet. Our findings were confirmed by the observation of 
SCUBE2 expression in human coronary artery with DIT and advanced lesion of atherosclerotic plaque. 
Previous investigations described that SCUBE2 mediates Hh signaling pathway. We have observed that 
SCUBE2 expression is associated with Sonic Hedgehog (Shh) and its receptor, Patched (Ptc), both in DIT 
and advanced plaque lesion. Our results suggested that SCUBE2 is a new target molecule in 
atherosclerosis and might play an important role in atherosclerotic plaque progression via Hh signal 
transduction. 
 
INTRODUCTION 
 
Atherosclerosis is known as the highest contributing factor of death caused by cardiovascular diseases. 
Atherosclerosis involves complex interactions of molecules. Many experimental and clinical approaches have 
attempted to identify several candidate molecules and pathways responsible for the progression of the 
atherosclerotic plaque. Over several years, the importance of inflammation during all stages of atherosclerosis, 
from its inception through its progression, has greatly increased. It is believed that the inflammatory molecules 
in early atherogenesis play a role for the fate of advanced lesion of atherosclerotic plaque formation (9, 16). 
Experimental studies have demonstrated that an inflammatory subset of monocytes/macrophages preferentially 
accumulate in inflammatory plaque and produce pro-inflammatory cytokines. Accumulating experimental 
evidence supports a key role for inflammation as a link between risk factors for atheroslcerosis and the biology 
that underlies the complications of this disease. But still the atherogenesis event remains challenging to be 
elucidated (10, 14).  
The epidermal growth factor (EGF) superfamily is a group of growth factors, cytokine-like mediators, and 
extracellular matrix proteins. One gene family named signal peptide CUB-EGF-like domain containing protein 
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(SCUBE) encodes secreted proteins harboring  nine copies of EGF-like repeats, a spacer region, three 
cysteine-rich domains, and one CUB domain at the C terminus. The SCUBE family is composed of three 
independent genes, SCUBE1, 2, and 3. SCUBE1 to 3 are expressed in various types of tissues and cells of 
human, mouse and zebrafish. (4, 25, 27, 28, 29, 31). Little is known on how the SCUBE family is involved in 
cardiovascular diseases. The gene SCUBE1 was first identified in human vascular endothelial cells (31) and has 
been reported to be expressed in platelets and human atherosclerotic vascular lesion. SCUBE1 is released by 
activated platelets, and enhances platelet – platelet adhesion and agglutination (25). Recent investigation 
revealed that SCUBE1 expression is elevated in patients with acute coronary syndrome and acute large-vessel 
atherothrombotic stroke (4). However, the biological function of SCUBE1 in atherosclerosis or thrombus 
formation is still unclear. Like SCUBE1, SCUBE2, a protein closely related to SCUBE1, was described as cell 
surface protein on the vascular endothelium. The expression of both SCUBE1 and SCUBE2 are rapidly 
downregulated by interleukin-1β or TNF-α (31) which indicates a potential involvement of the SCUBE proteins 
in inflammation. In humans, SCUBE1 was only detected in endothelial cells and platelets while SCUBE2 is 
expressed in a broad spectrum of human tissues including cardiovascular tissues (28, 31). SCUBE2 might 
therefore have some functions in cardiovascular diseases. SCUBE2 was initially reported to play a role in 
embryogenic development. On the basis of genetic studies, it was suggested that you gene, the zebrafish 
orthologue of the mammalian SCUBE2 gene, acts as a permissive factor for Hedgehog (Hh) signaling upstream 
of Smoothened (SMO), the Hh receptor signal component (11, 13, 26). Tsai et al, reported that SCUBE2 forms a 
complex with Sonic hedgehog (Shh) and its receptor Patched-1 (Ptc1) in vitro to promote the Shh-induced 
signaling. SCUBE2 represents a novel positive component in the propagation of the Hh signal (3, 12, 24) and 
may have significant implications for Hh-mediated biological processes during development and Hh-related 
human pathologies.  
In our present study, we have found that SCUBE2 is expressed in the injured carotid artery and aortic sinus 
of two different animal models of DIT and atherosclerotic plaque (carotid artery ligation and LDL-/- mice fed 
with high fat diet) as well as in human atherosclerotic arteries. Expression of SCUBE2 was gradually elevated 
following plaque progression in aortic sinus in the atherosclerotic mouse model. Consistently we have also found 
SCUBE2 to be expressed in both human coronary artery with DIT and advanced lesion of atherosclerotic plaque. 
Macrophage presence was not detectable in DIT, as lesion progressed however, macrophage infiltration occurred. 
SCUBE2 was colocalized not only with macrophages, but also with ApoB, Shh, and Ptc1 in advanced plaque. 
SCUBE2 may act on macrophage through Hh signals and induce atherosclerosis progression. Our study implied 
that SCUBE2 might be a new target molecule that plays a role in atherosclerosis lesion.   
 
MATERIAL AND METHODS 
 
Carotid artery ligation  
Nine male 10-week-old C57BL/6J mice weighing 20 – 25 grams were used in all experiments. The animals 
were anesthetized using isoflurane inhalation and the left carotid arteries were dissected and ligated near the 
bifurcation. One or two weeks after the injury, the ligated left carotid arteries and sham operated right carotid 
arteries were collected for subject of analysis.  
Low-density lipoprotein receptor knockout (LDLr-/-) mice fed with high fat diet 
LDLr-/- mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). The LDLr-/- mice were fed 
standard CRF-1 mouse chow (Charles River Laboratories International, Inc.) until 10 – 12 weeks of age. 
Subsequently, they were switched to western diet with 1.5% cholesterol to stimulate a high fat diet (D12079B, 
Research Diets, Inc., NJ, USA). Whole aortas were collected and used for analyzing mRNA expression. The 
heart containing aortic sinus was frozen in Tissue-Tek OCT (Sakura Finetek USA, Inc.) for cryosectioning.  
This study was approved by the Kobe Pharmaceutical University Animal Care and Use Committee, and 
animal experiments were conducted in accordance with the Regulations for Animal Experimentation of Kobe 
Pharmaceutical University, Act on Welfare and Management of Animals (Law No. 105; 1973, revised 2006), the 
Standards Relating to the Care and Management of Laboratory Animals and Relief of Pain (Notification No. 88, 
2006), and the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in 
Academic Research Institutions (Notice No. 71, 2006).   
RT-PCR and Real-Time PCR  
Total mRNAs were extracted from aorta of mice using RNAisol (Takara Bio.Inc., Tokyo, Japan). A 
ReverTra Ace RT PCR Kit (Toyobo Co. Ltd, Japan) was used for reverse transcription. Real-time PCR using a 
7500 Real-Time PCR System (Applied Biosystems, Japan) and Rotor Gene Q Series (Qiagen, Japan) with a Two 
Step SYBR® RT-PCR Kit (Toyobo Co. Ltd, Japan). The following primers were used for amplification : mouse 
SCUBE2 : forward, AGA CTT ATG AAC GCC CCA TC and reverse, TAG AGC CTG CCA TCT CGA AC; 
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mouse GAPDH: forward, TGT GTC CGT CGT GGA TCT GA and reverse, TTG CTG TTG AAG TCG CAG 
GAG.  
 
 
Human autopsy material  
Human coronary arteries were obtained from 20 autopsy cases (aged 15 – 84 years) after informed consent 
was provided by their families. The clinical investigation conformed to the principles outlined in the Declaration 
of Helsinki, and was approved by the Institutional Review Board of Kobe University Graduate School of 
Medicine. Formalin-fixed human coronary artery samples were sectioned and subjected to hematoxylin-eosin 
(H-E) staining, immunohistochemistry and immunofluorescence staining.  
Immunostaining 
Formalin-fixed human coronary artery sections were deparaffinized, hydrated and subjected to antigen 
retrieval by microwave heating with strong heat 5 minutes and weak heat 10 minutes. Serial sections of human 
coronary arteries were incubated overnight with goat polyclonal human anti-SCUBE2 antibody (Santa Cruz 
Biotechnology), α-actin smooth muscle (Invitrogen) and mouse monoclonal human anti-CD68 (Dako Corp., 
Japan). For immunofluorescence double staining, following the incubation of anti SCUBE2 overnight, rabbit 
polyclonal anti Shh (Santa Cruz Biotechnology Inc. USA) was assessed. Fluorescence signals were detected 
using anti goat Alexa 488 (Invitrogen) and anti rabbit Alexa 594 (Invitrogen). The nuclei were visualized using 
DAPI (Molecular Probes). Immunofluorescence microscopy was performed using Olympus IX 71.  
Murine carotid arteries were embedded in OCT compound immediately after euthanasia, section and fixed in 
cold acetone for 20 minutes. Carotid arteries and serial sections of sinus aortic were incubated overnight with 
rabbit polyclonal anti SCUBE2 antibody (Abcam Plc.), α-actin smooth muscle (invitrogen) and Mac3 (BD 
Pharmingen).  
Statistical analysis 
All data are presented in mean and standard error of mean. Statistically significant differences of SCUBE2 
expression between mice with carotid ligation and sham operated mice was analyzed using the Mann-Whitney U 
test. Differences of SCUBE2 expression in normal diet, 4 weeks, and 8 weeks after beginning of high fat diet in 
LDLr-/- were compared using one-way analysis of variance followed by Fisher’s protected least significant 
difference (PLSD) test with equal or unequal variances. Values of P <0.05 were considered significant.   
 
RESULTS 
 
Diffuse intimal thickening (DIT) is an early stage of atherosclerosis in humans. In order to know whether 
SCUBE2 is related to DIT, we performed left carotid artery ligation in mice as an animal model of human DIT. 
Ligated carotid arteries and sham operated control arteries were collected to study gene expression of SCUBE2 
from 1 week and 2 weeks after injury. After 1 week ligation, SCUBE2 expression level started to increase 
(Figure 1A). Extended to 2 weeks after ligation, mRNA level of SCUBE2 was noticeably up-regulated compared 
to sham operated control (Figure 1B).  
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Figure 1. mRNA expression level of SCUBE2. One week after left carotid artery ligation, mRNA expression level of 
SCUBE2 started to increase (A). Extended to two weeks after ligation, mRNA level of SCUBE2 was significantly 
up-regulated (B). Immunohistochemistry serial section of SCUBE2, α-SMA, and F4/80 in sham operated carotid artery (C, D, 
E). SCUBE2, α-SMA, and F4/80 serial section two weeks after carotid artery ligation in C57BL/6J mice. At this stage, 
SCUBE2 co-localized dominantly with α-actin SMA, and to a lesser extent with F4/80 (F, G, H).   
 
Further, we investigated SCUBE2 expression in DIT using serial section of immunohistochemistry in the 
carotid artery (Figure 1C-H). Two weeks after carotid artery ligation, thickened intima expressed SCUBE2 
abundantly and a lesser amount was found in the medial layer (Figure 1F). Thickened intima layer which 
predominantly consisted of an α-actin positive cells, exhibited a co-localization with SCUBE2. F4/80 positive 
cells were in small amount and some of them were incorporated with SCUBE2 (Figure 1H). We identified the 
SCUBE2 expression in smooth muscle cells (SMCs) abundantly in the mice which underwent the model of DIT. 
In order to mimic human atherosclerosis process, we fed LDLr-/- mice with high fat diet for 4 weeks as an 
early stage of atherosclerosis and for 8 weeks as a progressive stage of atherosclerosis. SCUBE2 mRNA level of 
whole aorta was increased significantly in LDLr-/- mice after eight weeks feeding with high fat diet (Figure 2A). 
To investigate which cells expressed SCUBE2, we performed immunohistochemistry staining with serial section 
of aortic sinus of LDLr-/- mice fed with high fat diet after 4 weeks (Figure 2E, F, G) and 8 weeks (Figure 2H, I, 
J). Plaque formation in aortic sinus was abundantly found in LDLr-/- after 8 weeks fed with high fat diet (Figure 
2H, I, J). Both α-actin positive cells (Figure 2F) and Mac3, macrophage marker positive cells (Figure 2G) 
showed to express SCUBE2 (Figure 2E) 4 weeks after beginning of high fat diet. After 8 weeks with high fat 
diet, plaque lesion progressed and SCUBE2 was strongly expressed in the plaque lesion (Figure 2F, I, J).  
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Figure 2. SCUBE2 expression in LDLr-/- mice fed with high fat diet (HFD). mRNA expression level of SCUBE2 
increased markedly in LDLr-/- mice after 8 weeks fed with HFD (n = 3 – 6) (A). Serial section of SCUBE2, α-SMA, and Mac 
3 in LDLr-/- mice fed with and without high fat diet. SCUBE2 expression seemed to increase after 4 weeks HFD and 
progressed after 8 weeks HFD compared to control (B, E, H). Co-localization of SCUBE2 with α-actin SMA and 
macrophage marker, Mac 3, showed strongly in 4 weeks and 8 weeks after HFD (C, F, I, D, G, J) 
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We extended our study on the role of SCUBE2 in human atherosclerosis by using human coronary artery 
with several stages of atherosclerosis. DIT is dominantly composed of SMCs both in intimal layer and medial 
layer. Macrophage infiltration has not been detected in this stage. SCUBE2 was detected in both intimal layer 
and medial layer of DIT in human coronary artery (Figure 3A, B, C). In an early plaque progressive stage of 
human coronary artery, macrophage infiltration increased and plaque formation was detected (Figure 3D, E, F). 
SCUBE2 was expressed scanty in the plaque area (Figure 3D). α-SMA positive cells were also expressed scanty 
and co-localized with SCUBE2 (Figure 3E). CD68 positive cells were apparent, infiltrated in the plaque area and 
co-localized with SCUBE2 strongly (Figure 3F).  
As atherosclerosis progressed, plaque area was expanded. SCUBE2 was observed strongly in near-surface 
parts of the intimal layer. In other parts of the plaque, SCUBE2 was expressed scanty. α-SMA positive cells 
were detected in the area where SCUBE2 was expressed scanty (Figure 3G, H). In contrast, CD68 positive cells 
were strongly expressed with SCUBE2 in near-surface parts of intimal layer (Figure 3G, I). We confirmed using 
immunofluorescence staining that cells expressing SCUBE2 were co-localized with α-actin positive SMCs in 
DIT (Figure 3J-O). As lesion progressed, SCUBE2 stained cells were co-localized with α-actin positive SMCs 
and CD68 in some parts (Figure 3P-U). 
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Figure 3. SCUBE2 expression in human coronary artery. Serial section of SCUBE2, α-SMA, and CD68 in human 
coronary artery consisting DIT, progressed lesion and advanced plaque, 100x magnification (A-I). 200x magnification of 
diffuse intimal thickening in human coronary artery (J-O). SCUBE2 co-localized with α-actin positive SMCs (J-L). 
Macrophage was not detected at this stage (M-O). 200x magnification of advanced lesion of atherosclerotic plaque (P-U). 
Macrophage infiltration was detected (S-U). Dotted lines indicate the intimal : medial boundary.  
 
We have found that SCUBE2 was co-localized with CD68 positive cells in the advanced lesion of 
atherosclerotic plaque. Next, we confirmed whether SCUBE2 was co-localized with ApoB. We have detected 
that SCUBE2 expressing cells also showed an ApoB positive staining in human coronary artery (Figure 4). 
 
 
 
Figure 4. SCUBE2 co-localization with ApoB positive cells in human coronary artery. SCUBE2 was co-localized with 
apoB accumulation in advanced atherosclerosis plaque of human coronary artery.   
 
As previously reported, SCUBE2 is regarded to mediate Shh signal transduction. We therefore investigated 
whether SCUBE2 was incorporated with Shh and its receptor, Ptc. Using serial section of immunohistochemistry 
staining on human coronary artery, we have found that SCUBE2 was co-localized with Shh in DIT (Figure 5A, 
B) and also in advanced plaque lesion (Figure 5C, D). Further, we confirmed our findings using 
immunofluorescence double staining of SCUBE2 and Shh. We have found that SCUBE2 was incorporated with 
Shh as well (data not shown).  
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Figure 5. SCUBE2 co-localization with Shh. Immunohistochemistry staining of SCUBE2 and Sonic Hedgehog (Shh) 
co-localization in human coronary artery consisting DIT and advanced plaque 
 
Ptc is known as hedgehog protein receptor. To confirm whether SCUBE2 was also incorporated with Ptc, we 
performed serial section of immunohistochemistry staining on human coronary artery. Consistent to hedgehog 
signaling, we have observed that SCUBE2 was also co-localized with Ptc both in DIT (Figure 6A, B) and in 
advanced plaque lesion (Figure 6C, D).  
 
 
Figure 6. SCUBE2 incorporated with Patched (Ptc) receptor. Immunohistochemistry staining of SCUBE2 and patched 
receptor co-localization in human coronary artery with DIT and advanced plaque. 
 
DISCUSSION 
 
In this study we demonstrated that SCUBE2 was related to the development and progression of 
atherosclerosis in human coronary artery. Moreover, we have observed that SCUBE2 was co-localized with Shh 
and also with its receptor Ptc especially in the advanced plaque where macrophage infiltration and foam cell 
formation were found abundantly. This is the first evidence of the involvement of SCUBE2 in atherosclerosis.  
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At first, we used a mouse model of DIT or neointima formation, which is a model for an early stage of 
atherosclerosis in human. Unlike in humans, intimal layer in mice aorta is thin. Carotid artery was ligated to 
mimic DIT or neointima formation. After ligation of carotid artery, it is believed that in response to vascular 
injury, SMCs migrated into the intima layer and proliferate there like they do in the medial layer (18, 19, 20, 22). 
SCUBE2 co-localization with α-actin positive smooth muscle cells indicated that up-regulation of its expression 
was related to SMCs migration and proliferation in neointima formation. 
Further, we focused on SCUBE2 expression during atherosclerosis process. Mimicking human 
atherosclerosis process, LDLr-/- mice treated with high fat diet were found to progressively form a plaque in 
aortic sinus 8 weeks after beginning of the high fat diet. Expression of SCUBE2 was gradually elevated together 
with the plaque formation in aortic sinus. This significant difference in SCUBE2 mRNA expression between 4 
weeks and 8 weeks after beginning of high fat diet might be correlated with plaque formation. SCUBE2 was 
strongly expressed in the plaque area and was co-localized with macrophage marker positive cells. These results 
indicated that SCUBE2 was strongly related to the accumulation of macrophages and the formation of plaque.  
Using this atherosclerosis mouse model, we could provide evidences that SCUBE2 played a role in 
atherosclerosis. Furthermore, we investigated SCUBE2 in DIT as an early atherosclerotic event and extend our 
investigation to advanced lesion of atherosclerotic plaque. We detected SCUBE2 in DIT. At this early 
atherosclerotic stage, SCUBE2 was diffusely distributed in the thickened intima and showed a co-localization 
with α-actin positive SMCs. Following an early plaque progressive lesion, SCUBE2 was distributed in the 
vicinity of atherosclerotic plaque and showed co-localization with α-actin positive SMCs. SCUBE2 was also 
associated with macrophages. The co-localization of SCUBE2 and macrophage became prominent in advanced 
lesion of atherosclerotic plaque.  
Previous studies reported that SCUBE2 was found to mediate Shh protein release and activated Hh signal 
transduction. SCUBE2 also enhanced Shh binding to its receptor, Ptc (3, 11, 12, 13, 24, 26). We could confirm 
these observations with our immunochemical study where detection of SCUBE2 was associated with Shh and its 
receptor Ptc both in DIT and advanced lesion. The relation of hedgehog signaling with cardiovascular diseases is 
still disputed (5). Kusano et al reported that Shh-induced vasculature in Shh-treated diabetic rats showed a 
significantly larger vessels and greater number of α-actin positive cells (15). This study was then supported by 
Morrow et al, who investigated the effect of Shh overexpression in both rat and human smooth muscle cells 
(SMCs). They have observed that hedgehog stimulation resulted in a significant elevation of SMCs proliferation. 
It is believed that Hedgehog stimulation on SMCs growth is induced through Notch signaling. Further, after 
vascular injury by ligation of carotid artery in mice, intima SMCs expressed abundantly Ptc1 receptor and Gli 
(an Hh target gene) implying Shh activation in these cells (17).  
Moreover, a study by Dunaeva et al demonstrated that Shh induced human monocyte chemotaxis obtained 
from diabetes mellitus (DM) patients with and without coronary artery disease (CAD) as well as a higher 
expression of Ptc among them compared to control (6). Recent findings from Athanasiadis et al on genetic 
determinants of plasma β2-glycoprotein I levels (β2-GPI) phenotype revealed that SCUBE2 is strongly related 
with this gene (1). In atherosclerotic lesion, β2-GPI has been reported to be expressed in endothelial cells and 
monocyte/macrophages. This molecule also has been identified in human carotid plaques after carotid 
endarterectomy and a higher level was found in plasma of patients with ischemic heart disease and unstable 
angina (7, 8). How SCUBE2 and β2-GPI are connected in atherosclerosis is not described yet.  
Based on previous evidences indicating that SCUBE2 is upstream the Shh signaling pathway, we can 
speculate that SCUBE2 upregulation in early stage of atherosclerosis may activate Shh signal transduction. 
Bijlsma et al hypothesized that Hh signaling is transferred from LDL particles located in thickened intima, 
induces SMCs proliferation and migration, and modulates T-lymphocyte cell progression, activation, and 
cytokine production (2). In addition, an observation in drosophila indicates that lipophorin are required for the 
transport of highly hydrophobic Hh molecules. In mammals, LDL might also be loaded with Hh and play a role 
as carrier protein (21). These facts might be put in perspective with our finding on SCUBE2. We may 
hypothesize that the abundant LDL particles present in thickened intima, might upregulate SCUBE2 expression 
in this stage. An increased release of Shh and its receptor Ptc might thus occur. The elevated Shh may induce 
SMCs proliferation, increase monocyte chemotaxis, and upregulate several growth factors as previously 
investigated.  
In conclusion, we have shown that the secreted and membrane anchored SCUBE2 was present in diffuse 
intima thickening and advanced lesion of atherosclerotic plaque. Even though the atherosclerosis processes in 
humans and mice differ in term of vessel size, structure, hydrodynamics, embryonic origin, abundance of SMCs 
and elasticity (23), we could observed the same pattern of SCUBE2 expression during the process in both 
species. Taken together, SCUBE2 might represent a new target molecule for atherosclerosis. The expression of 
SCUBE2 in the SMCs and macrophages/foam cells of human coronary artery indicated a potential role in SMCs 
proliferation, migration or cell differentiation and inflammation reaction through hedgehog signaling pathway in 
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atherosclerotic plaque. Further investigation of the potential implications of SCUBE2 in atherosclerosis is 
needed.  
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